Luspatercept for Anemia
Phase 2
70
about 3.6 years
18+
1 site in FL
Why this study is shown
What this study is about
Researchers are testing whether luspatercept, a medication, can help people with anemia related to Myelodysplastic Syndromes (MDS) or Myeloproliferative Neoplasm (MPN) need fewer blood transfusions. The trial will also evaluate the safety and tolerability of luspatercept in these patients.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Luspatercept
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
luspatercept
Secondary: Duration of Response, Incidence of treatment related adverse events
Oncology